ETFS

Clear Creek Financial Management LLC increased its stake in shares of Amazon.com, Inc. (NASDAQ:AMZN – Free Report) by 0.9% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 49,263 shares of the e-commerce giant’s stock after buying an additional 461 shares during the period. Amazon.com comprises

Warning: Undefined array key 0 in /home/etfdailynews/public_html/wp-content/themes/responsalambre/functions.php on line 144 wp-content/themes/responsalambre/images/image-pending.gif&w=240&h=240&zc=2″ class=”ff-og-image-inserted”> Ihear a lot of financial advisors (on the financial news networks) discussing how their clients like Treasury bills at current yields. The idea is that investors can safely invest in T-bills and avoid the next stock market crash. I have some thoughts on

Asset Management One Co. Ltd. boosted its stake in Willis Towers Watson Public Limited (NASDAQ:WTW – Free Report) by 1.9% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 45,354 shares of the company’s stock after buying an additional 825 shares during the quarter.

Warning: Undefined array key 0 in /home/etfdailynews/public_html/wp-content/themes/responsalambre/functions.php on line 144 wp-content/themes/responsalambre/images/image-pending.gif&w=240&h=240&zc=2″ class=”ff-og-image-inserted”> Active investors typically hold a lot of different types of securities in their brokerage accounts. From interacting with my newsletter subscribers, I know that many of them think of every investment in their brokerage account as “stocks”; however, much of what we own

FSM Wealth Advisors LLC increased its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 7.4% during the first quarter, HoldingsChannel.com reports. The fund owned 18,597 shares of the biopharmaceutical company’s stock after buying an additional 1,277 shares during the period. FSM Wealth Advisors LLC’s holdings in Pfizer were worth $759,000 at the end of

AE Wealth Management LLC grew its stake in shares of Cleveland-Cliffs Inc. (NYSE:CLF – Free Report) by 109.3% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 22,630 shares of the mining company’s stock after purchasing an additional 11,818 shares during the period. AE Wealth Management

Lifestyle Asset Management Inc. acquired a new stake in Chevron Co. (NYSE:CVX – Free Report) during the first quarter, according to its most recent filing with the SEC. The firm acquired 1,254 shares of the oil and gas company’s stock, valued at approximately $205,000. Other hedge funds and other institutional investors have also recently bought

Louisiana State Employees Retirement System lessened its position in shares of InterDigital, Inc. (NASDAQ:IDCC – Free Report) by 10.6% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 12,600 shares of the Wireless communications provider’s stock after selling 1,500 shares during

Mid-America Apartment Communities (NYSE:MAA – Free Report) had its target price increased by Truist Financial from $159.00 to $174.00 in a research note released on Friday, FlyOnTheWall reports. Other equities research analysts have also issued reports about the company. Wolfe Research lowered Mid-America Apartment Communities from a peer perform rating to an underperform rating and

Warning: Undefined array key 0 in /home/etfdailynews/public_html/wp-content/themes/responsalambre/functions.php on line 144 wp-content/themes/responsalambre/images/image-pending.gif&w=240&h=240&zc=2″ class=”ff-og-image-inserted”> One of the hottest topics of conversation on Wall Street, and among my colleagues like Tim Plaehn and Tim Melvin here at Investors Alley, is the state of the U.S. commercial real-estate market (CRE). The story on Wall Street, as articulated by media

AmpliTech Group (NASDAQ:AMPG – Free Report) is one of 37 publicly-traded companies in the “Communications equipment, not elsewhere classified” industry, but how does it compare to its peers? We will compare AmpliTech Group to similar companies based on the strength of its analyst recommendations, dividends, profitability, risk, institutional ownership, earnings and valuation. Profitability This table

Warning: Undefined array key 0 in /home/etfdailynews/public_html/wp-content/themes/responsalambre/functions.php on line 144 wp-content/themes/responsalambre/images/image-pending.gif&w=240&h=240&zc=2″ class=”ff-og-image-inserted”> Earlier this morning, an ADP jobs report was released showing that the private sector added 497,000 jobs in June, as well as sending Treasury yields higher. This caused stocks to slide pretty significantly as investors weighed the repercussions of these developments on the

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) has been assigned a consensus rating of “Buy” from the nine brokerages that are currently covering the company, Marketbeat.com reports. Nine analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokerages that have updated their coverage on the stock in the

Warning: Undefined array key 0 in /home/etfdailynews/public_html/wp-content/themes/responsalambre/functions.php on line 144 wp-content/themes/responsalambre/images/image-pending.gif&w=240&h=240&zc=2″ class=”ff-og-image-inserted”> With the start of the third quarter of 2023, I am struck by the tremendous opportunities for investors from the different high-yield categories. Business operations are stable to growing, yields are fantastic, and share values remain below historical norms. Investors who get into

Yamato (OTCMKTS:YATRY – Free Report) and Mullen Group (OTCMKTS:MLLGF – Free Report) are both industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings. Dividends Yamato pays an annual dividend of $12.06 per share and

Vigilare Wealth Management reduced its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,347 shares of the company’s stock after selling 362 shares during the period.